维持性血液透析患者心血管疾病患病情况及危险因素分析
[Abstract]:Objective to investigate the prevalence and risk factors of cardiovascular disease (CVD) in patients with maintenance hemodialysis (MHD). Methods from October 2013 to October 2014, 472 patients with end-stage kidney disease who were treated by hemodialysis in blood purification center of 7 tertiary hospitals in Zhengzhou were selected. Collect general information of all patients and relevant laboratory results. Patients were divided into CVD group and no CVD group according to whether cardiovascular events occurred. T test and 蠂 2 test were used to compare the difference of the above indexes between the two groups. Then the risk factors of cardiovascular disease in hemodialysis patients were analyzed by Logistic regression analysis. Results in 472 patients with MHD, the mean age was 55.60 卤11.93 years, male 243, female 229, mean dialysis age 39.30 卤21.85 months. The incidence of cardiovascular events in 56.4%.CVD group was compared with that in no CVD group, age, systolic blood pressure before dialysis. Before dialysis, there were significant differences in serum creatinine (Scr), (UA), cystatin C (Cys-C), urea clearance index (Kt/V), triglyceride (TG), hypersensitive C-reactive protein (hs-CRP), serum phosphorus and type B brain natriuretic peptide (BNP) (P0.05). Hemoglobin (Hb), total protein (TP), albumin (ALB), total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), low density lipoprotein cholesterol (LDL-C), serum calcium, total parathyroid hormone (iPTH), before dialysis urea nitrogen (BUN) had no significant difference. Age of hemodialysis, serum uric acid, cystatin C, triglyceride and hypersensitive C-reactive protein were risk factors of CVD in hemodialysis patients. Conclusion (1) the incidence of cardiovascular disease in MHD patients is high and should be actively prevented and treated. 2, age, dialysis age, serum uric acid, cystatin C, triglyceride and hypersensitive C-reactive protein may be independent risk factors for cardiovascular disease in MHD patients.
【学位授予单位】:郑州大学
【学位级别】:硕士
【学位授予年份】:2017
【分类号】:R692.5;R54
【参考文献】
相关期刊论文 前10条
1 王立瑞;李江涛;余晨;;维持性血液透析患者甲状旁腺素水平与左心室肥厚关系的研究[J];临床肾脏病杂志;2016年10期
2 安坤;;血液透析患者与持续不卧床腹膜透析患者心绞痛发生率对比分析[J];中国现代药物应用;2016年20期
3 李强;张全;;血液透析患者甲状旁腺激素对心脏结构和功能的影响[J];中国医药指南;2016年27期
4 陈忠辉;何静;;维持性血液透析患者血管钙化相关因素研究[J];蚌埠医学院学报;2016年09期
5 豆利军;王国平;闵瘤芳;张顺国;;维持性血液透析患者血胱抑素、NT-proBNP水平与心血管事件发生的相关性分析[J];现代中西医结合杂志;2016年26期
6 钱莹;常安瑾;俞海瑾;陈孜瑾;马晓波;陈晓农;陈楠;;清晨高血压在维持性血液透析患者中的检测及其临床意义[J];中国血液净化;2016年01期
7 李春明;;血清同型半胱氨酸、成纤维细胞生长因子23、klotho蛋白与血液透析患者心血管功能关系研究[J];中国实验诊断学;2015年11期
8 唐雪莲;万静芳;林利容;卢晓梅;霍本刚;何娅妮;李开龙;;维持性血液透析患者清晨高血压与心脑血管事件的关系[J];中国血液净化;2015年08期
9 玄先法;王玉新;李清芹;张以勤;周丽娜;叶婧;;终末期肾病血液透析患者心血管疾病危险因素分析[J];中华临床医师杂志(电子版);2015年13期
10 张丽洁;张爱华;朱宁;崔专;田信奎;庄震;张枫;苏春燕;范敏华;;血液透析患者血红蛋白变异性和与新发心脑血管事件及动静脉内瘘血栓形成有关[J];中国血液净化;2015年06期
相关硕士学位论文 前4条
1 陈源;中晚期慢性肾脏病患者矿物质和骨异常与心脏损害之间的相关性分析[D];福建医科大学;2015年
2 沈立婷;血清胱抑素C与终末期肾病患者心脑血管并发症的相关性研究[D];吉林大学;2014年
3 钟晓菁;维持性血液透析患者血红蛋白变异性与心脑血管事件及死亡的相关性研究[D];复旦大学;2013年
4 闫敏;维持性血液透析患者发生心血管不良事件的影响因素分析[D];山东大学;2012年
,本文编号:2265091
本文链接:https://www.wllwen.com/linchuangyixuelunwen/2265091.html